Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-12-23

Clinical Trial Update: Depression Related Improvement With Vardenafil for Erectile Response [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating vardenafil for erectile dysfunction with depression completed, reporting depression-related improvement in erectile response.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levitra (vardenafil)

Snippet

Sponsor: Bayer | Conditions: Erectile Dysfunction, Depression | Phase 3 | Status: COMPLETED